Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2

Journal of Virology

Volumn 82, Issue 15, 2008, Pages 7456-7466

  Lucchesi, Walter ^a   Brady, Gareth ^a   Dittrich Breiholz, Oliver ^b   Kracht, Michael ^c   Russ, Rainer ^d   Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^d GENEDATA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; EPSTEIN BARR VIRUS ANTIGEN 2; LATENT MEMBRANE PROTEIN 1;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE CONTROL; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS STRAIN;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CXCR; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 4 TYPE 1;

EID: 47749096011     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00223-08     Document Type: Article

References (52)

1. Aderem, A. 1992. The MARCKS brothers: a family of protein kinase C substrates. Cell 71:713-716.
2. Amon, W., U. K. Binne, H. Bryant, P. J. Jenkins, C. E. Karstegl, and P. J. Farrell. 2004. Lytic cycle gene regulation of Epstein-Barr virus. J. Virol. 78:13460-13469.
3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. Tuffnell, and B. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
4. Balabanian, K., B. Lagane, S. Infantino, K. Y. Chow, J. Harriague, B. Moepps, F. Arenzana-Seisdedos, M. Thelen, and F. Bachelerie. 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280:35760-35766.
5. Bates, E. E., W. H. Fridman, and C. G. Mueller. 2002. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12. Immunogenetics 54:96-105.
6. Birkenbach, M., K. Josefsen, R. Yalamanchili, G. Lenoir, and E. Kieff. 1993. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67:2209-2220.
7. Brady, G., G. J. MacArthur, and P. J. Farrell. 2007. Epstein-Barr virus and Burkitt lymphoma. J. Clin. Pathol. 60:1397-1402.
8. Buryskova, M., M. Pospisek, A. Grothey, T. Simmet, and L. Burysek. 2004. Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J. Biol. Chem. 279:4017-4026.
9. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
10. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81:7632-7636.
11. de Jesus, O., P. R. Smith, L. Spender, C. Elgueta Karstegl, H. H. Niller, D. Huang, and P. J. Farrell. 2003. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 84:1443-1450.
12. Dolan, A., C. Addison, D. Gatherer, A. J. Davison, and D. J. McGeoch. 2006. The genome of Epstein-Barr virus type 2 strain AG876. Virology 350:164-170.
13. Garibal, J., E. Hollville, A. I. Bell, G. L. Kelly, B. Renouf, Y. Kawaguchi, A. B. Rickinson, and J. Wiels. 2007. Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A. J. Virol. 81:7598-7607.
14. Glaser, M., S. Wanaski, C. A. Buser, V. Boguslavsky, W. Rashidzada, A. Morris, M. Rebecchi, S. F. Scarlata, L. W. Runnels, G. D. Prestwich, J. Chen, A. Aderem, J. Ahn, and S. McLaughlin. 1996. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J. Biol. Chem. 271:26187-26193.
15. Gong, J., F. Traganos, and Z. Darzynkiewicz. 1994. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218:314-319.
16. Gordadze, A. V., R. Peng, J. Tan, G. Liu, R. Sutton, B. Kempkes, G. W. Bornkamm, and P. D. Ling. 2001. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. J. Virol. 75:5899-5912.
17. Infantino, S., B. Moepps, and M. Thelen. 2006. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J. Immunol. 176:2197-2207.
18. Janssen, A., P. Johansson, S. Li, and L. Rymo. 2007. Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site. J. Gen. Virol. 88:1887-1894.
19. Janssen, A., P. Johansson, W. Yang, L. Palmqvist, A. Sjoblom-Hallen, and L. Rymo. 2007. Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation. Virus Genes 35:203-214.
20. Jenkins, P., U. Binné, and P. Farrell. 2000. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74:710-720.
21. Jochner, N., D. Eick, U. Zimber-Strobl, M. Pawlita, G. W. Bornkamm, and B. Kempkes. 1996. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. EMBO J. 15:375-382.
22. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J. Virol. 69: 253-262.
23. Kelly, G., A. Bell, and A. Rickinson. 2002. Epstein-Barr virus-associated Burkitt iymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8:1098-1104.
24. Kempkes, B., D. Spitkovsky, P. Jansen-Durr, J. W. Ellwart, E. Kremmer, H. J. Delecluse, C. Rottenberger, G. W. Bornkamm, and W. Hammerschmidt. 1995. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 14:88-96.
25. Kieff, E., and A. Rickinson. 2001. Epstein-Barr virus and its replication, p. 2511-2573. In D. Knipe and P. Howley (ed.), Fields virology, 4th ed. Lippincott, Philadelphia, PA.
26. Krauer, K. G., D. K. Belzer, D. Liaskou, M. Buck, S. Cross, T. Honjo, and T. Sculley. 1998. Regulation of interleukin-lbeta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP. Virology 252:418-430.
27. Laux, G., F. Dugrillon, C. Eckert, B. Adam, U. Zimber-Strobl, and G. W. Bornkamm. 1994. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J. Virol. 68:6947-6958.
28. Maier, S., G. Staffler, A. Hartmann, J. Hock, K. Henning, K. Grabusic, R. Mailhammer, R. Hoffmann, M. Wilmanns, R. Lang, J. Mages, and B. Kempkes. 2006. Cellular target genes of Epstein-Barr virus nuclear antigen 2. J. Virol. 80:9761-9771.
29. McCann, E. M., G. L. Kelly, A. B. Rickinson, and A. I. Bell. 2001. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a coactivator of EBNA2 function. J. Gen. Virol. 82:3067-3079.
30. Myat, M. M., S. Anderson, L. A. Allen, and A. Aderem. 1997. MARCKS regulates membrane ruffling and cell spreading. Curr. Biol. 7:611-614.
31. Raggo, C., R. Ruhl, S. McAllister, H. Koon, B. J. Dezube, K. Fruh, and A. V. Moses. 2005. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res. 65:5084-5095.
32. Rickinson, A. B., L. S. Young, and M. Rowe. 1987. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310-1317.
33. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
34. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:4084-4092.
35. Sjoblom, A., A. Jansson, W. Yang, S. Lain, T. Nilsson, and L. Rymo. 1995. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter. J. Gen. Virol. 76:2679-2692.
36. Sjoblom, A., W. Yang, L. Palmqvist, A. Jansson, and L. Rymo. 1998. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter. J. Virol. 72:1365-1376.
37. Spender, L. C., W. Lucchesi, G. Bodelon, A. Bilancio, C. E. Karstegl, T. Asano, O. Dittrich-Breiholz, M. Kracht, B. Vanhaesebroeck, and P. J. Farrell. 2006. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. J. Gen. Virol. 87:2859-2867.
38. Spender, L. C., H. J. Whiteman, C. E. Karstegl, and P. J. Farrell. 2005. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 24:1873-1881.
39. Stoermann, B., K. Kretschmer, S. Duber, and S. Weiss. 2007. B-1a cells are imprinted by the microenvironment in spleen and peritoneum. Eur. J. Immunol. 37:1613-1620.
40. Stumpo, D. J., C. B. Bock, J. S. Tuttle, and P. J. Blackshear. 1995. MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc. Natl. Acad. Sci. USA 92:944-948.
41. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
42. Tatsuta, T., J. Cheng, and J. D. Mountz. 1996. Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis. J. Immunol. 157:3949-3957.
43. Wang, F., H. Kikutani, S. F. Tsang, T. Kishimoto, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65:4101-4106.
44. Wang, F., S. F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64:3407-3416.
45. Werman, A., R. Werman-Venkert, R. White, J. K. Lee, B. Werman, Y. Krelin, E. Voronov, C. A. Dinarello, and R. N. Apte. 2004. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 101:2434-2439.
46. Wu, D. Y., G. V. Kalpana, S. P. Goff, and W. H. Schubach. 1996. Epstein-Barr virus nuclear protein 2 binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J. Virol. 70:6020-6028.
47. Wu, D. Y., A. Krumm, and W. H. Schubach. 2000. Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. J. Virol. 74:8893-8903.
48. Wu, D. Y., D. C. Tkachuck, R. S. Roberson, and W. H. Schubach. 2002. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity. J. Biol. Chem. 277:27706-27715.
49. Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
50. Zeng, M. S., D. J. Li, Q. L. Liu, L. B. Song, M. Z. Li, R. H. Zhang, X. J. Yu, H. M. Wang, I. Ernberg, and Y. X. Zeng. 2005. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J. Virol. 79:15323-15330.
51. Zhao, B., S. Maruo, A. Cooper, R. C. M., E. Johannsen, E. Kieff, and E. Cahir-McFarland. 2006. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 103:1900- 1905.
52. Zimber-Strobl, U., E. Kremmer, F. Grasser, G. Marschall, G. Laux, and G. W. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12:167-175.